Combinatory Effect of Jerantinine A and Chemotherapeutic Agent in Regulating Spliceosome in Breast Cancer Stem Cells and Non-Stem Breast Cancer Cells
Abstract only Background: Breast cancer is the second most common cancer and is afflicting women globally. Current standard regimen of chemotherapy includes 2 main classes of drug anthracycline (e.g., doxorubicin) and taxane (e.g., paclitaxel). Two main issues are associated with these drugs: toxici...
Gespeichert in:
Veröffentlicht in: | Journal of global oncology 2018-10, Vol.4 (Supplement 2), p.218-218s |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!